We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$2.13B
AUM Growth
-$37.9M
Cap. Flow
-$145M
Cap. Flow %
-6.81%
Top 10 Hldgs %
95.95%
Holding
27
New
3
Increased
–
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$68.7M
2
LMND icon
Lemonade
LMND
+$51.8M
3
TSHA icon
Taysha Gene Therapies
TSHA
+$15.1M

Top Sells

Rank Stock Value
1
ONEM
1Life Healthcare
ONEM
+$225M
2
SDGR icon
Schrodinger
SDGR
+$41.1M
3
SNAP icon
Snap
SNAP
+$12.3M
4
GRTS
Gritstone bio, Inc. Common Stock
GRTS
+$1.42M
5
ATER icon
Aterian
ATER
+$1.14M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 49.76%
2 Healthcare 29.57%
3 Technology 18.74%
4 Financials 1.93%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JD icon
1
JD.com
JD
$44.6B
$1.05B 49.41%
13,553,474
– –
LYFT icon
2
Lyft
LYFT
$6.02B
$353M 16.6%
12,828,509
– –
DXCM icon
3
DexCom
DXCM
$31.5B
$332M 15.6%
3,222,724
– –
RCUS icon
4
Arcus Biosciences
RCUS
$3.55B
$86.6M 4.07%
5,049,786
– –
RLAY icon
5
Relay Therapeutics
RLAY
$4.1B
$76.7M 3.6%
+1,801,490
New +$68.7M
LMND icon
6
Lemonade
LMND
$3.74B
$41M 1.93%
+824,743
New +$51.8M
WORK
7
DELISTED
Slack Technologies, Inc.
WORK
$34.9M 1.64%
1,299,771
– –
RAPT
8
DELISTED
RAPT Therapeutics
RAPT
$26.9M 1.26%
104,507
– –
DNTH icon
9
Dianthus Therapeutics
DNTH
$5.84B
$22.7M 1.07%
208,696
– –
BEAM icon
10
Beam Therapeutics
BEAM
$2.63B
$16.3M 0.77%
663,691
– –
TSHA icon
11
Taysha Gene Therapies
TSHA
$1.68B
$14.4M 0.67%
+640,882
New +$15.1M
SPRO icon
12
Spero Therapeutics
SPRO
$67.7M
$12.4M 0.58%
1,112,473
– –
IDYA icon
13
IDEAYA Biosciences
IDYA
$3.42B
$9.46M 0.44%
753,187
– –
QNCX icon
14
Quince Therapeutics
QNCX
$22.9M
$9.46M 0.44%
946
– –
AUTL
15
Autolus Therapeutics
AUTL
$397M
$8.13M 0.38%
698,262
– –
ATER icon
16
Aterian
ATER
$4.45M
$7.43M 0.35%
75,060
-12,936
-15% -$1.14M
EVLO
17
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$5.59M 0.26%
53,025
– –
FULC icon
18
Fulcrum Therapeutics
FULC
$273M
$5.38M 0.25%
678,141
-4,099
-0.6% -$49.4K
CLDR
19
DELISTED
Cloudera, Inc.
CLDR
$4.66M 0.22%
427,710
– –
CRWD icon
20
CrowdStrike
CRWD
$194B
$4.26M 0.2%
124,080
– –
ALEC icon
21
Alector
ALEC
$168M
$1.85M 0.09%
175,866
– –
UBER icon
22
Uber
UBER
$143B
$1.52M 0.07%
41,585
– –
GRTS
23
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1.45M 0.07%
547,488
-381,534
-41% -$1.42M
DBX icon
24
Dropbox
DBX
$7.6B
$251K 0.01%
13,033
– –
SDGR icon
25
Schrodinger
SDGR
$1.13B
– –
-448,722
Closed -$41.1M
1
2

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q3 2020 Portfolio in Review

As of Q3 2020, Alphabet Inc held 27 positions worth $2.13B, down 1.8% from $2.17B the previous quarter. Its ten largest holdings account for 96% of the portfolio.

Alphabet Inc withdrew a net $145M in Q3 2020, closing 3 positions and reducing 3 holdings. Its most notable exit was 1Life Healthcare, an estimated $225M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 38% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Alphabet Inc opened a new position in Relay Therapeutics worth $76.7M.

  • Alphabet Inc's largest Q3 2020 buy was Relay Therapeutics: 1,801,490 shares worth $76.7M.
  • Alphabet Inc's biggest Q3 2020 reduction was Gritstone bio, Inc. Common Stock, cutting an estimated $1.42M.
  • Alphabet Inc fully exited 1Life Healthcare in Q3 2020, selling an estimated $225M.
  • Alphabet Inc's ten largest holdings make up 96% of its $2.13B portfolio in Q3 2020.
  • Alphabet Inc opened 3 new positions and closed 3 in Q3 2020.
  • Alphabet Inc's portfolio value fell 1.8% quarter-over-quarter to $2.13B.

Based on Alphabet Inc's 13F filing for Q3 2020, filed 15 Nov 2022.